Andy Batts
Growth at reasonable price, deep value, healthcare, tech

Qiagen: Why I Prefer Waiting On The Sidelines

Netherlands-based Qiagen N.V. (NASDAQ:QGEN) is a leading global provider of sample and assay technologies. The company aims to accelerate growth in 2014 primarily by boosting the global adoption of its QIAsymphony platform and establishing the QuantiFeron-TB platform as the modern gold standard for latent tuberculosis control....

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.